1/2

Export Ready

Ceritinib 150mg capsule

Name: Ceritinib 150mg capsule
SKU: 8484137
Availability: InStoreOnly

Sold by ayursatva pharma llp · Raigad, Maharashtra, India

Price

Price on request

In stock

Inclusive of all taxes

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for ayursatva pharma llp.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Raigad Dispatch on request Verified seller

ayursatva pharma llp

Verified seller · Raigad, Maharashtra, India

Registered address: RAIGAD, India.

View profile All products

Established

Not shared

Employees

–

GST

27ACGFA6465R1ZM

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Not shared

Turnover

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

Ceritinib is used in the treatment of cancer.

Product Description

Ceritinib is used in the treatment of cancer.

Description provided by ayursatva pharma llp.

Specifications

Molecular Formula	C28H36ClN5O3
Molecular Weight	563.1 g/mol
Capsule Strength	150 mg Ceritinib per capsule
Pharmacological Class	Tyrosine kinase inhibitor
Shelf Life	Typically 2 years from manufacturing
Storage Conditions	Store below 30°C; protect from moisture and light
Manufacturer	To be specified by supplier
Therapeutic Indication	ALK-positive NSCLC
Regulatory Approval	Approved by CDSCO for specific indications
Administration Guidelines	Take orally on an empty stomach for optimal absorption

Use cases

Category	Pharmaceuticals > Oncology Medicines > Targeted Cancer Therapy > ALK Inhibitors
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Ceritinib 150mg capsule. Answers compiled from verified sellers' commercial terms and platform data.

Q: Is Ceritinib 150mg capsule suitable for patients resistant to crizotinib?

A: Yes, Ceritinib 150mg capsule is specifically indicated for treating ALK-positive NSCLC patients who have developed resistance or intolerance to crizotinib, providing an effective alternative targeted therapy.

Q: What is the recommended administration condition for Ceritinib 150mg capsules?

A: Ceritinib 150mg capsules should be taken orally on an empty stomach to ensure optimal bioavailability and efficacy.

Q: Can Ceritinib 150mg capsules be used for cancers other than ALK-positive NSCLC?

A: Ceritinib is primarily approved for treating ALK-positive non-small cell lung cancer, and use for other cancers should only be under strict clinical guidance or trial protocols.

Q: How does Ceritinib 150mg capsule work in targeting lung cancer?

A: Ceritinib selectively inhibits the ALK tyrosine kinase activity, a protein responsible for the growth and survival of certain cancer cells, thus blocking tumor proliferation in ALK-positive lung cancer patients.

Q: What storage conditions are recommended for maintaining the efficacy of Ceritinib capsules?

A: Ceritinib 150mg capsules should be stored below 30°C, protected from moisture and light to maintain stability and potency.

Question not answered? Ask sellers directly — typical response within 4 hours.